Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

The aim of this study was to assess the prognostic role of co-morbidity in severe chronic obstructive pulmonary disease (COPD). A cohort of 270 COPD patients, mean (+/-SD) age 67+/-9 yrs, consecutively discharged from a University Hospital after an acute exacerbation was studied. Mean (+/-SD) forced expiratory volume in one second (FEV1) was 34+/-16% of predicted and FEV1/forced vital capacity (FVC) was 40.5+/-13.8%. The most common co-morbid diseases were: hypertension (28%), diabetes mellitus (14%), and ischaemic heart disease (10%). Clinical, electrocardiogram (ECG), and respiratory function data taken at the time of discharge were collected from the clinical records. The Charlson's index was used to quantify co-morbidity. Follow-up was conducted by means of telephone calls. Multivariate survival analysis was used to identify the independent predictors of death. The median survival of the cohort was 3.1 yrs. Death was predicted by the following variables: age (hazard rate (HR) 1.04; 95% confidence intervals (95% CI) 1.02-1.05), ECG signs of right ventricular hypertrophy (HR 1.76; 95% CI 1.30-2.38), chronic renal failure (HR 1.79; 95% CI 1.05-3.02), ECG signs of myocardial infarction or ischaemia (HR 1.42; 95% CI 1.02-1.96), FEV1 < 590 mL (HR 1.49; 95% CI 0.97-2.27). A score based upon these variables predicted mortality at 5 yrs with a sensitivity of 63% and a specificity of 77%. Selected co-morbid diseases and electrocardiogram signs of right ventricular hypertrophy play a major prognostic role in advanced chronic obstructive pulmonary disease. The clinical assessment of patients with chronic obstructive pulmonary disease should include these important and easily measurable variables.

This article has been cited by other articles:

				F. Luppi, F. Franco, B. Beghe, and L. M. Fabbri Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 848 - 856. [Abstract] [Full Text] [PDF]

				D. M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur. Respir. J., October 1, 2008; 32(4): 962 - 969. [Abstract] [Full Text] [PDF]

				A. Faustini, C. Marino, D. D'Ippoliti, F. Forastiere, V. Belleudi, and C. A. Perucci The impact on risk-factor analysis of different mortality outcomes in COPD patients Eur. Respir. J., September 1, 2008; 32(3): 629 - 636. [Abstract] [Full Text] [PDF]

				L. Moro, C. Pedone, S. Scarlata, V. Malafarina, F. Fimognari, and R. Antonelli-Incalzi Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease Angiology, July 1, 2008; 59(3): 357 - 364. [Abstract] [PDF]

				J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz Cardiac Disease in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 543 - 548. [Abstract] [Full Text] [PDF]

				W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make Comorbidities in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 549 - 555. [Abstract] [Full Text] [PDF]

				D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Mueller, M. Tamm, and C. Mueller Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD Chest, May 1, 2008; 133(5): 1088 - 1094. [Abstract] [Full Text] [PDF]

				M T Dransfield, S M Rowe, J E Johnson, W C Bailey, and L B Gerald Use of {beta} blockers and the risk of death in hospitalised patients with acute exacerbations of COPD Thorax, April 1, 2008; 63(4): 301 - 305. [Abstract] [Full Text] [PDF]

				M Stafoggia, F Forastiere, D Agostini, N Caranci, F de'Donato, M Demaria, P Michelozzi, R Miglio, M Rognoni, A Russo, et al. Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis J Epidemiol Community Health, March 1, 2008; 62(3): 209 - 215. [Abstract] [Full Text] [PDF]

				D. J. Lederer, E. K. T. Benn, R. G. Barr, J. S. Wilt, G. Reilly, J. R. Sonett, S. M. Arcasoy, and S. M. Kawut Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 450 - 454. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				C. Hernandez and J. Roca COPD exacerbations: who is safe to be managed at home Chronic Respiratory Disease, November 1, 2007; 4(4): 187 - 188. [PDF]

				J. Tkac, S. F. P. Man, and D. D. Sin Review: Systemic consequences of COPD Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 47 - 59. [Abstract] [PDF]

				A. Anzueto, S. Sethi, and F. J. Martinez Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564. [Abstract] [Full Text] [PDF]

				D. A Seamark, C. J Seamark, and D. M G Halpin Palliative care in chronic obstructive pulmonary disease: a review for clinicians J R Soc Med, May 1, 2007; 100(5): 225 - 233. [Abstract] [Full Text] [PDF]

				C. Cote, M. D. Zilberberg, S. H. Mody, L. J. Dordelly, and B. Celli Haemoglobin level and its clinical impact in a cohort of patients with COPD Eur. Respir. J., May 1, 2007; 29(5): 923 - 929. [Abstract] [Full Text] [PDF]

				D. Stolz, M. Christ-Crain, N. G. Morgenthaler, J. Leuppi, D. Miedinger, R. Bingisser, C. Muller, J. Struck, B. Muller, and M. Tamm Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD Chest, April 1, 2007; 131(4): 1058 - 1067. [Abstract] [Full Text] [PDF]

				Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan Chest, March 1, 2007; 131(3): 705 - 710. [Abstract] [Full Text] [PDF]

				British Thoracic Society Guideline Development Gro Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline Thorax, March 1, 2007; 62(3): 200 - 210. [Full Text] [PDF]

				D. D. Sin, E. Wong, I. Mayers, D. C. Lien, D. Feeny, H. Cheung, W. Q. Gan, and S. F. P. Man Effects of Nocturnal Noninvasive Mechanical Ventilation on Heart Rate Variability of Patients With Advanced COPD Chest, January 1, 2007; 131(1): 156 - 163. [Abstract] [Full Text] [PDF]

				D. D. Sin, N. R. Anthonisen, J. B. Soriano, and A. G. Agusti Mortality in COPD: role of comorbidities Eur. Respir. J., December 1, 2006; 28(6): 1245 - 1257. [Abstract] [Full Text] [PDF]

				N. Stenfors Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Ostersund, Sweden: Patient Characteristics and Estimated Prevalence. Chest, September 1, 2006; 130(3): 666 - 671. [Abstract] [Full Text] [PDF]

				S. Marti, X. Munoz, J. Rios, F. Morell, and J. Ferrer Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur. Respir. J., April 1, 2006; 27(4): 689 - 696. [Abstract] [Full Text] [PDF]

				E H Baker, C H Janaway, B J Philips, A L Brennan, D L Baines, D M Wood, and P W Jones Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease Thorax, April 1, 2006; 61(4): 284 - 289. [Abstract] [Full Text] [PDF]

				Poster presentations Thorax, December 1, 2005; 60(suppl_2): ii53 - ii120. [Full Text] [PDF]

				J J Soler-Cataluna, M A Martinez-Garcia, P Roman Sanchez, E Salcedo, M Navarro, and R Ochando Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax, November 1, 2005; 60(11): 925 - 931. [Abstract] [Full Text] [PDF]

				F. Holguin, E. Folch, S. C. Redd, and D. M. Mannino Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001 Chest, October 1, 2005; 128(4): 2005 - 2011. [Abstract] [Full Text] [PDF]

				L. Huiart, P. Ernst, and S. Suissa Cardiovascular Morbidity and Mortality in COPD Chest, October 1, 2005; 128(4): 2640 - 2646. [Abstract] [Full Text] [PDF]

				C. Ai-Ping, K.-H. Lee, and T.-K. Lim In-Hospital and 5-Year Mortality of Patients Treated in the ICU for Acute Exacerbation of COPD: A Retrospective Study Chest, August 1, 2005; 128(2): 518 - 524. [Abstract] [Full Text] [PDF]

				K Miyazaki, N Kikuchi, H Satoh, K Sekizawa, M L G Janssen-Heijnen, and J W W Coebergh Comorbidity in elderly NSCLC patients Thorax, August 1, 2005; 60(8): 704 - 704. [Full Text] [PDF]

				T. A. C. Nizet, F. J. J. van den Elshout, Y. F. Heijdra, M. J. T. van de Ven, P. G. H. Mulder, and H. Th. M. Folgering Survival of Chronic Hypercapnic COPD Patients Is Predicted by Smoking Habits, Comorbidity, and Hypoxemia Chest, June 1, 2005; 127(6): 1904 - 1910. [Abstract] [Full Text] [PDF]

				C. P. Hersh, D. L. DeMeo, E. Al-Ansari, V. J. Carey, J. J. Reilly, L. C. Ginns, and E. K. Silverman Predictors of Survival in Severe, Early Onset COPD Chest, November 1, 2004; 126(5): 1443 - 1451. [Abstract] [Full Text] [PDF]

				K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD Chest, August 1, 2003; 124(2): 459 - 467. [Abstract] [Full Text] [PDF]

				R. Pistelli, P. Lange, and D.L. Miller Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity Eur. Respir. J., May 1, 2003; 21(40_suppl): 10S - 14s. [Abstract] [Full Text] [PDF]

				T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 544 - 549. [Abstract] [Full Text] [PDF]

				A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, M. Felez, A. Khalaf, R. M. Marrades, E. Monso, J. Serra-Batlles, et al. Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 680 - 685. [Abstract] [Full Text] [PDF]

				V. S. Fan, J. R. Curtis, S.-P. Tu, M. B. McDonell, and S. D. Fihn Using Quality of Life to Predict Hospitalization and Mortality in Patients With Obstructive Lung Diseases* Chest, August 1, 2002; 122(2): 429 - 436. [Abstract] [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				P. Almagro, E. Calbo, A. Ochoa de Echaguen, B. Barreiro, S. Quintana, J. L. Heredia, and J. Garau Mortality After Hospitalization for COPD* Chest, May 1, 2002; 121(5): 1441 - 1448. [Abstract] [Full Text] [PDF]

				M. Cazzola, P. Noschese, G. D'Amato, and M. G. Matera The Pharmacologic Treatment of Uncomplicated Arterial Hypertension in Patients With Airway Dysfunction Chest, January 1, 2002; 121(1): 230 - 241. [Abstract] [Full Text] [PDF]

				M. L. Nevins and S. K. Epstein Predictors of Outcome for Patients With COPD Requiring Invasive Mechanical Ventilation Chest, June 1, 2001; 119(6): 1840 - 1849. [Abstract] [Full Text] [PDF]

				M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Eur. Respir. J., May 1, 2001; 17(5): 928 - 933. [Abstract] [Full Text] [PDF]

				J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer Epidemiology of chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 982 - 994. [Abstract] [Full Text] [PDF]

				M. Moretti, C. Cilione, A. Tampieri, C. Fracchia, A. Marchioni, and S. Nava Incidence and causes of non-invasive mechanical ventilation failure after initial success Thorax, October 1, 2000; 55(10): 819 - 825. [Abstract] [Full Text]

				H. F Guite, R. Dundas, and P. G J Burney Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma Thorax, April 1, 1999; 54(4): 301 - 307. [Abstract] [Full Text]